© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 29, 2015
In patients with chronic HBV, the immune system may have very low levels of the virus. When reactivation occurs due to immunosuppression, these viruses begin to replicate again. Common symptoms of this event include inflammation of the liver and elevations of liver enzyme levels in the blood. In some cases, bilirubin levels may rise in response to reactivation of infection.
April 09, 2015
Lemtrada (alemtuzumab) injection is approved for the management of relapsing forms of multiple sclerosis (MS). In general, use of Lemtrada should be limited to patients with MS who have not had therapeutic success with 2 or more prior treatments.
February 16, 2015
For the first time, an oral therapy has been proved to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.
Increased salt intake may magnify the risk of relapses in patients with multiple sclerosis (MS). According to researchers, excess dietary sodium intake is associated with a higher level of disease activity in patients with relapsing-remitting MS.